Megalencephaly-capillary Malformation Polymicrogyria Syndrome (MCAP) Clinical Trials in Philadelphia, Pennsylvania

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)